Ginkgo Bioworks Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Fiserv president resigns, interim leaders named for financial unit
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Ginkgo Bioworks (DNA) Misses Q2 EPS by 36c, Raises Guidance
August 15, 2022 4:05 PM EDTGinkgo Bioworks (NYSE: DNA) reported Q2 EPS of ($0.41), $0.36 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $145 million versus the consensus estimate of $78.83 million.
GUIDANCE:
Ginkgo Bioworks sees FY2022 revenue of $425-440 million, versus the consensus... More
